Clinical trial
Escitalopram and Sleep Architecture in Patients With Major Depressive Disorder
NCT00442481 · Sheba Medical Center, Other · Unknown status
Key facts
| NCT number | NCT00442481 |
|---|---|
| Title | Escitalopram and Sleep Architecture in Patients With Major Depressive Disorder |
| Official title | Escitalopram and Sleep Architecture in Patients With Major Depressive Disorder |
| Lead sponsor | Sheba Medical Center, Other |
| Collaborators | Lundbeck Israel Industry |
| Status | Unknown status |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Major Depressive Disorder |
| Intervention type | Drug, Procedure |
| Interventions | Escitalopram, A baseline overnight polysomnography (oPSG) |
| Enrollment | 25 |
| Start date | Feb 1, 2007 |
| First posted | Mar 2, 2007 |
| Last update posted | Mar 2, 2007 |
| Countries | Israel |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: